XTalks
JULY 14, 2022
There is no doubt that business-to-business (B2B) life science webinars allow you to connect with potential and current customers in a very personal way. There are certainly a lot of benefits that can come with using this medium, so why not perfect your webinar marketing campaign with professional webinar production services?
Pharmaceutical Technology
JULY 28, 2022
In the life sciences sector, one country is significantly outstripping others for FDI. Data shows that almost 40% of all life sciences subsidiaries are located in the US. After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Industry clusters.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 2, 2023
Anavex Life Sciences has secured new US intellectual property compositions patent for its ANAVEX 2-73 (blarcamesine). We are extremely pleased with the continued development of the patent portfolio for ANAVEX 2-73 (blarcamesine) which demonstrates our continued commitment to protecting all aspects of the Anavex product portfolio.”
XTalks
FEBRUARY 14, 2024
This includes first-in-class immunotherapy products such as novel antibodies and CAR T-cell treatments targeting CTLA-4. OncoImmune was founded in 2000 based on the scientific discoveries of the company’s founders who moved their lead product from a basic concept into clinical trials for multiple indications.
XTalks
APRIL 3, 2024
Bruce Culleton, MD Chief Executive Officer ProKidney ProKidney’s lead product candidate, REACT, is an investigational cell therapy designed to stabilize or improve kidney function in patients with chronic kidney disease with diabetes as the primary cause. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.
XTalks
FEBRUARY 14, 2023
The life science industry is constantly evolving, making it difficult to stay ahead of the curve. Digital transformation is burgeoning and we aim to cover some of the dominant emerging technologies that are currently running the life science industry by storm.
pharmaphorum
OCTOBER 28, 2022
The sooner a human-centred perspective is applied to the development of either a drug or device product, the more likely the product will be adopted and used because it’s been designed around what the end consumer wants and needs. This will ensure that you are developing a product these audiences will use.
Expert insights. Personalized for you.
98 
Let's personalize your content